Therapeutic Specialties Archives | Page 17 of 31 | Certara

Publication

Population Pharmacokinetics and Exposure-response of Osimertinib in Patients with Non-small Cell Lung Cancer

CertaraDecember 18, 2016

Publication

Intravenous Topiramate: Pharmacokinetics in Dogs with Naturally Occurring Epilepsy

CertaraDecember 5, 2016

Publication

The Pharmacokinetics of Transdermal Flunixin Meglumine in Holstein Calves

This study describes the pharmacokinetics of topical and intravenous (IV) flunixin meglumine in Holstein calves.…

CertaraDecember 1, 2016

Publication

Modeling and Experimental Studies of Obeticholic Acid Exposure and the Impact of Cirrhosis Stage

CertaraDecember 1, 2016

Publication

A Randomized Dose Escalation Study of Intravenous Baclofen in Healthy Volunteers: Clinical Tolerance and Pharmacokinetics

CertaraNovember 17, 2016

Publication

Impact of Target-mediated Elimination on the Dose and Regimen of Evolocumab, a Human Monoclonal Antibody Against Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9)

CertaraNovember 15, 2016

Blog

Modeling and Simulation Guides Dosing for a New Anti-psychotic Drug

Drug development is becoming more complex than ever. Regulatory agencies expect sponsors to consider a…

CertaraOctober 21, 2016

Publication

Profiling the Relationship Between Tumor-associated Macrophages and Pharmacokinetics of Liposomal Agents in Preclinical Murine Models

CertaraOctober 5, 2016

Publication

Gulp1 is Associated with the Pharmacokinetics of PEGylated Liposomal Doxorubicin (PLD) in Inbred Mouse Strains

CertaraOctober 1, 2016

Brochure

Rare Disease and Orphan Drug Development

There are 7,000 rare diseases impacting 350 million patients worldwide, yet only 300 of these…

CertaraAugust 3, 2016

© 2026 Certara. All Rights Reserved. | Legal | Privacy policy